MicroRNAs in idiopathic childhood nephrotic syndrome

Aditi Sinha, Arvind Bagga(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Aijaz Ahmed(Stanford University), Saumyaranjan Mallick(All India Institute of Medical Sciences), Himanshi Saini(All India Institute of Medical Sciences), Kshetrimayum Ghanapriya Devi, Manraj Singh(All India Institute of Medical Sciences)
Clinical and Experimental Nephrology
December 4, 2024
10.1007/s10157-024-02595-3
Cited by 1

Related Papers

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216